SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-027547
Filing Date
2021-05-13
Accepted
2021-05-13 16:10:49
Documents
14
Period of Report
2021-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K atha-8k_20210513.htm   iXBRL 8-K 37202
2 EX-99.1 atha-ex991_67.htm EX-99.1 143272
3 GRAPHIC guldvxr03kmp000001.jpg GRAPHIC 123256
  Complete submission text file 0001564590-21-027547.txt   485572

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA atha-20210513.xsd EX-101.SCH 5748
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE atha-20210513_lab.xml EX-101.LAB 20227
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atha-20210513_pre.xml EX-101.PRE 12063
7 EXTRACTED XBRL INSTANCE DOCUMENT atha-8k_20210513_htm.xml XML 3686
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39503 | Film No.: 21919721
SIC: 2836 Biological Products, (No Diagnostic Substances)